跳至主要内容
临床试验/NCT04006184
NCT04006184已完成不适用

Venaseal Versus Ablation With Endothermal Laser or Radiofrequency for Saphenous Vein Incompetence: a Comparison of Utilization of Adjunctive Phlebectomy

Lake Washington Vascular1 个研究点 分布在 1 个国家目标入组 547 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
547
试验地点
1
主要终点
Adjunctive phlebectomy

研究概览

简要总结

This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenous Laser Ablation).

详细描述

This single site, retrospective, comparison study aims to review up to 400 treated limbs with symptomatic varicose veins to compare the need for/utilization of adjunctive phlebectomy performed as a concomitant or staged procedure in conjunction with either cyanoacrylate closure versus endothermal ablation of incompetent saphenous veins through 6 months of the index procedure. The overall cost of treatment for both groups will be compared.

Some of the secondary aims of this study include:

  1. To assess changes in Clinical, Etiology, Anatomy, and Pathology (CEAP) clinical class after completion of treatment.
  2. To assess changes in revised Venous Clinical Severity Score (rVCSS) and compare the two groups.
  3. To assess the need for adjunctive therapies.
  4. To record and compare retrospectively the adverse events between the two groups.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Limb with saphenous vein incompetence, treated with one of the following:
  • VenaSeal ™ Endovenous Laser Ablation Radiofrequency Ablation
  • CEAP Clinical Class between 2-5
  • Limb treated from October 1st, 2015-present
  • At least 2 months of follow-up post index procedure
  • Treatment of either the great saphenous vein (GSV), the small saphenous vein (SSV), or both. Treatment of accessory saphenous veins (ASV) is allowed as long as either the GSV, SSV, or both the GSV and SSV were treated as well in that limb at the index procedure.

排除标准

  • Limb treatment of the accessory saphenous vein (ASV) without concomitant great saphenous vein (GSV) and/or small saphenous vein (SSV) treatment
  • Limb treatment for reasons other than symptomatic varicose veins
  • Limbs without follow-up information at least 2 months following the index procedure
  • Subjects who participated in another clinical trial as part of their saphenous vein treatment
  • Investigator decision (concurrent condition that would make inclusion inappropriate, protected subject population) -

结局指标

主要结局

Adjunctive phlebectomy

时间窗: Through 6 months of index procedure

Compare need for/utilization of adjunctive phlebectomy performed as a concomitant or staged procedure

Cost of Treatment

时间窗: Through six months of index procedure

A cost analysis will be performed calculating the total cost of treatment between groups

次要结局

  • Severity of Disease(At treatment through six months of index procedure)
  • Utilization of adjunctive treatments(Through six months of index procedure)
  • Adverse events reported during clinic visits(Though six months of index procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验